Ovarian cancers metastasize by shedding into the peritoneal fluid and dispersing to distal sites within the peritoneum. Monolayer cultures do not accurately model the behaviors of cancer cells within a nonadherent environment, as cancer cells inherently aggregate into multicellular structures which contribute to the metastatic process by attaching to and invading the peritoneal lining to form secondary tumors. To model this important stage of ovarian cancer metastasis, multicellular aggregates, or spheroids, can be generated from established ovarian cancer cell lines maintained under nonadherent conditions. To mimic the peritoneal microenvironment encountered by tumor cells in vivo, a spheroidmesothelial co-culture model was established in which preformed spheroids are plated on top of a human mesothelial cell monolayer, formed over an extracellular matrix barrier. Methods were then developed using a real-time cell analyzer to conduct quantitative real time measurements of the invasive capacity of different ovarian cancer cell lines grown as spheroids. This approach allows for the continuous measurement of invasion over long periods of time, which has several advantages over traditional endpoint assays and more laborious real time microscopy image analyses. In short, this method enables a rapid, determination of factors which regulate the interactions between ovarian cancer spheroid cells invading through mesothelial and matrix barriers over time.
Introduction
Ovarian cancer has the highest mortality rate of all gynaecological cancers 1 . Worldwide, there are ~230,000 cases and over 100,000 deaths due to the disease each year 1 . Most patients (>75%) are diagnosed after the cancer has already metastasized, when treatment is further complicated by increased resistance to chemotherapy and the prognosis is poor 2 . Patients with stage III-IV metastatic disease have 5 year survival rates of only 30-40% 3 . Thus, there is an urgent need for a better understanding of the cellular behaviors underlying ovarian cancer metastasis in order to effectively treat advanced disease.
The current model of ovarian cancer metastasis proposes several steps in the metastatic process, each of which occurs in a distinct microenvironment which impacts on tumor behavior. Metastasizing ovarian cancer cells initially are shed from the primary tumor site and survive in a nonadherent state within the peritoneal fluid as single cells or three-dimensional multicellular structures, termed multicellular aggregates or spheroids 2, 4, 5 . Cells which do not form spheroids in suspension are more susceptible to anoikis 2, 4, 5 . Spheroids also exhibit increased resistance to chemotherapeutics, contributing to residual disease and subsequent recurrence of the cancer 2, 4, 5 . A second critical step in ovarian cancer metastasis is the transition of aggregates from free-floating clusters to established secondary tumors within the peritoneal wall and omentum 5, 6 . Cell-cell and cell-substrate interactions have been implicated in aggregate formation, survival, and adherence to the extracellular matrix (ECM) produced by the mesothelial lining of the peritoneum [4] [5] [6] [7] [8] [9] [10] [11] . As yet, these processes are poorly understood.
To define the mechanisms involved in the dissemination of ovarian cancers, spheroids can be generated from established cancer cell lines using nonadherent culture methods, maintaining cells in suspension either by adding methylcellulose to the culture media 12, 13 or by culturing cells on low-attachment plates 2, 14 . When cultured in this manner, ovarian cancer cells assemble into multicellular aggregates or spheroids which exhibit similar cellular, molecular, and biochemical properties to those of tumor aggregates found in vivo 2, 14 . After formation, spheroids can be subsequently harvested from the nonadherent medium and replated onto a variety of solid surfaces for further functional studies. This represents an advance over assays in monolayer culture, which do not accurately model the behaviors of ovarian cancer cells metastasizing within a nonadherent environment such as the intraperitoneal fluid.
The invasive capacity of cancer spheroids can be assessed in traditional endpoint assays in Boyden chambers 2 , but this approach can be misleading, as ovarian cancer cell invasion is a dynamic process over time. A recent real-time method has been devised using time-lapse video microscopy of mesothelial cell clearance by invading ovarian cancer spheroids 15 3. To add steps or substeps to the program, select the 'Schedule' tab and right click on 'Add a step'. The first step is a preprogrammed background sweep, which is automatically incorporated into the program once 'add a step' is chosen. 4. Enter the desired program details for Step 2 of the RTCA program, which will record readings during the establishment of the LP9 monolayer. Add the time intervals between impedance readings by selecting the 'Interval' tab and entering '15 min'. Add experimental duration by selecting the 'Duration' tab and entering a time between 12-24 hr. 5. To add subsequent steps, select the 'Schedule' tab and right click on 'Add a step' and enter details of the additional steps, as above.
Step 3 of the RTCA program will direct the instrument to take readings during spheroid invasion; enter '5 min' under the 'Interval' tab and '48 hr' under the 'Duration' tab. 6. Select 'Plate' on the menu bar and save. 
Harvest cancer spheroids generated under
Step 2 'Generation of spheroids in methylcellulose', above.
1. Aseptically, cut 1 mm off the top of a 1 ml pipette tip and use to gently retrieve the contents of each well. Transfer to a sterile tube . 2. Centrifuge spheroids at 120 x g for 8 min, and remove methylcellulose containing medium by gentle aspiration. 3. Wash spheroids twice more with PBS, centrifuging at 120 x g for 8 min to pellet spheroids after each wash. 4. For each experimental well, resuspend a total of 10 spheroids in 160 μl of medium without FBS. 5. Pause the RTCA experiment by selecting 'Execute' from the menu bar and checking 'Pause'. Remove the CIM plate from the instrument, and place in a tissue culture hood. Aspirate off the media from each well and replace with spheroid-containing media (10 spheres in 160 μl) or fresh media for LP9-only control wells.
6. Return the plate to the RTCA instrument. Select 'Execute' from the menu bar and check 'Abort step'. The program will move to the next step automatically. To resume the experiment, select 'Execute' from the menu bar and check 'Start/Continue'.
Step 3 in the RTCA program will initiate.
4. Data Analysis 1. To determine the level of spheroid cell invasiveness, subtract the values obtained for the LP9 monolayer only from the individual readings obtained for the ovarian cancer cell lines at each timepoint. 2. To plot 'spheroid invasion', normalize all values to the time point at which the spheroids were added to the plate, by setting that time point to '0'.
Representative Results
Ovarian cancer spheroids can be generated from many types of cell lines by culturing them in suspension or by harvesting primary tumor cells from malignant ascites 2, 14 . Here two epithelial ovarian cancer cell lines, OVCA433 and OVCA429, and an ovarian granulosa cell tumor line, KGN, have been used to generate spheroids ( Figure 1A) . In this method, cells are cultured in U-bottomed wells while suspended in media which has been made viscous by the addition of methylcellulose. Under these conditions, many ovarian cancer cells exhibit an inherent ability to aggregate to form spheroids 13 . Following overnight culture suspended in methylcellulose/media, all three cell lines formed compact spheroid structures of approximately 400-500 μm in diameter ( Figure 1A) . Meanwhile, the RTCA CIM plate is prepared, firstly by coating the porous membrane interface with matrix and then a confluent monolayer of human mesothelial cells (Figure 1B) . Once formed, spheroids are then transferred to the prepared CIM plate. Harvested cancer spheroids are plated on top of the LP9 monolayer and assessed as described below. Images under standard phase microscopy (or under fluorescent microscopy, if the optional cell labeling step was followed) of parallel cultures are taken periodically to aid in the interpretation of the RTCA data ( Figure 1C) .
It is informative to assess both the basal level of invasion of a cancer cell line, as well as chemoattractant-induced invasion. Typically, basal invasiveness is measured by the addition of SFM to both the upper and lower chambers. Complete media (10% FBS), which contains many potential chemoattractants, is used in the current example to examine 'chemoattractant-induced' invasion (Figure 2) . Parallel studies of LP9 mesothelial cells alone confirmed that these cells are minimally invasive over 2 days under either basal or 'chemoattractant' induced conditions and thus were a good cell type to use in co-culture assays with ovarian cancer cells (Figures 2A and 2B) . In contrast, ovarian cancer spheroids generated using any of the three cell lines exhibited the capacity to invade toward a chemoattractant (FBS) (Figures 2A-2C) . The major advantage of using the RTCA real time instruments over traditional endpoint assays is that changes in cell/spheroid behavior can be quantified over time. Over the 2 day assay, the KGN, OVCA429, and OVCA433 cell lines all exhibited the capacity to invade toward a chemoattractant (indicated by increasing cell indices) but low basal levels of invasion ( Figure 2C ). The cell lines exhibited similar rates of invasion, as indicated by the parallel slopes of the curves ( Figure 2C) ; however, the OVCA429 curve exhibited a higher upper asymptote, which indicated a higher maximal level of invasion compared to the other cell lines. Furthermore, the cell lines exhibited differences in their times to onset of invasion, with the KGN cells quickly invading the cell and matrix barriers and the OVCA433 and OVCA429 cells taking 3-5x longer to invade, respectively ( Figure 2D) . Importantly, their behaviors at the onset of invasion were not predictive of their overall capacity for invasion (Figures 2C and 2D) . This suggests different inherent capabilities of the cancer cell lines but also may indicate that different factors may regulate early and late invasive behaviors of spheroids. 
Discussion
Invading ovarian cancer cells interact with a variety of cell types at the surface of the peritoneum, including fibroblasts, adipocytes, and mesothelial cells, and bidirectional communication between the cancer cells and peritoneal cells is thought to play key roles in driving the metastatic process 2 . Once mastered, the protocol described herein is readily adaptable to the study of these interactions within the peritoneal microenvironment, e.g., through the addition of exogenous cytokines, growth factors, or specific inhibitors to the upper or lower chambers of the CIM plate well or genetic manipulation of the cancer or peritoneal cell lines. Furthermore, this method can be used with primary ovarian tumor cells harvested freshly from malignant ascites and/or primary peritoneal cells to gain direct insights into the regulatory signals and cellular interactions which govern the establishment of a metastatic lesion within the peritoneal cavity 2 .
Use of the RTCA instrument to measure the invasive capacity of single cells or spheroids offers several advantages over conventional single endpoint assays and time-lapse image analyses. The RTCA instrument measures cellular invasion at defined intervals continuously over the course of an assay, which can be hours or days. This enables the determination of changes in the rate of invasion over time, which overcomes the limitations of single endpoint assays. For example, examining the invasion data from the different cancer cell lines at a single endpoint (Figure 2) , e.g., 3 hr, might have led to the erroneous conclusion that KGN and OVCA433 cells were far more invasive than OVCA429 cells. Another advantage of this technology is that the RTCA instrument measures changes in electrical impedance. This means that assays can be run without labeling cells with an exogenous agent, which could have unintended effects on cell phenotype or function. This becomes particularly important when studying primary ovarian cancer cells derived from malignant ascites, with which it is imperative to keep manipulations to a minimum so as to avoid introducing molecular and phenotypic changes which are not reflective of their in vivo nature 2 . Furthermore, use of the RTCA instrument enables the collection of quantitative data in real time, which not only avoids the time consuming analyses associated with time-lapse microscopy but also enables the rapid determination of key experimental windows for assay optimization. This is particularly useful when comparing the effects of a range of factors on spheroid invasion, as different factors may exert their maximal effects at different timepoints or with greatly different profiles over time.
Although this protocol is amenable to alterations (e.g., use of different ECM matrix, different cancer cell lines, or different target cells), if doing so, it is important to note that various experimental conditions must first be optimized. For example, prior to commencing studies of spheroid invasion, the optimal number of cancer cells/CIM plate well should firstly be determined by assay of cell number titrations in monolayer culture. The optimal number of spheroids to use per well is then based on this analysis. For example, in the current method, spheroids comprise approximately 3,000 cells each when first generated. If initial cell number titrations indicate that 30,000 cells in monolayer are optimal for detection in invasion analyses, then 10 spheroids are added per CIM plate well. Furthermore, when conducting co-culture experiments, it is important to study the behaviors of the 'target' cell monolayer separately in order to determine whether these cells are inherently invasive, as this could confound the results. In the example demonstrated, cancer spheroids are plated on top of an LP9 cell monolayer, with and without FBS added to the bottom well as a chemoattractant. In parallel, LP9 cells are cultured alone, under each treatment condition. ECM barrier (Steps 3.1.1 -3.1.3) and conduct the assay in parallel with the ECM barrier in place. The latter 'invasion' measure can be corrected to the former 'migration' measure, if desired. Finally, it is important to note that the information gained from measures of electrical impedance is limited in scope: once cells have invaded into the bottom chamber, changes in their attachment, spreading, and proliferation on the underside of the membrane may contribute to changes in impedance readings. Therefore, this methodology is most informative when used in conjunction with other assays of spheroid cell viability, adhesion, migration, and morphology in order to comprehensively assess spheroid cell behaviors. For example, ideally, in order to fully understand spheroid-mesothelial interactions, separate co-cultures should also be imaged periodically under standard phase microscopy so that qualitative assessments of spheroid morphology and health can be made in parallel with quantitative RTCA assays of invasion. If the optional labeling step is performed, then the behaviors of single cancer cells can be determined under fluorescent microscopy as they disaggregate from the spheroid and interact with the unlabeled mesothelial cells. An added benefit of fluorescently labeling the cancer cells when co-culturing with a second cell type is that it is then possible to confirm that only the cancer cells have invaded through the cell and ECM barriers.
In summary, this method represents a high throughput quantitative analysis of ovarian cancer spheroid invasion of mesothelial and ECM barriers. Through the addition of exogenous cytokines, growth factors, or specific inhibitors to the upper or lower chambers of the CIM plate well, this method enables a rapid, determination of factors which regulate the interactions between ovarian cancer spheroid cells invading through mesothelial and matrix barriers over time.
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